OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis
Giulia Ferrannini, Lars H. Lund, Lina Benson, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 9, Iss. 1, pp. 10-17
Open Access | Times Cited: 12
Giulia Ferrannini, Lars H. Lund, Lina Benson, et al.
European Heart Journal - Cardiovascular Pharmacotherapy (2022) Vol. 9, Iss. 1, pp. 10-17
Open Access | Times Cited: 12
Showing 12 citing articles:
Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table
Francesco Cosentino, Subodh Verma, Philip Ambery, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4141-4156
Open Access | Times Cited: 17
Francesco Cosentino, Subodh Verma, Philip Ambery, et al.
European Heart Journal (2023) Vol. 44, Iss. 39, pp. 4141-4156
Open Access | Times Cited: 17
Risk phenotypes of diabetes and association with COVID-19 severity and death: an update of a living systematic review and meta-analysis
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 12
Sabrina Schlesinger, Alexander Lang, Nikoletta Christodoulou, et al.
Diabetologia (2023) Vol. 66, Iss. 8, pp. 1395-1412
Open Access | Times Cited: 12
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies
Zhi-Hui Song, Qiao-Ming Huang, Shan-Shan Xu, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 4, pp. 773-787
Closed Access | Times Cited: 3
Zhi-Hui Song, Qiao-Ming Huang, Shan-Shan Xu, et al.
Therapeutic Innovation & Regulatory Science (2024) Vol. 58, Iss. 4, pp. 773-787
Closed Access | Times Cited: 3
Association of anti-diabetic drugs and covid-19 outcomes in patients with diabetes mellitus type 2 and chronic kidney disease: Nationwide registry analysis
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0301056-e0301056
Open Access | Times Cited: 1
Antidiabetic Drug Efficacy in Reduction of Mortality during the COVID-19 Pandemic
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 4
Daniel Gonikman, Dmitrijs Kustovs
Medicina (2023) Vol. 59, Iss. 10, pp. 1810-1810
Open Access | Times Cited: 4
Does the Hyperglycemia Impact on COVID-19 Outcomes Depend upon the Presence of Diabetes?—An Observational Study
Inês Manique, Alexandra Abegão Matias, Bruno Bouça, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1116-1116
Open Access | Times Cited: 5
Inês Manique, Alexandra Abegão Matias, Bruno Bouça, et al.
Metabolites (2022) Vol. 12, Iss. 11, pp. 1116-1116
Open Access | Times Cited: 5
The impact of preadmission/prediagnosis use of GLP‐1 receptor agonists on COVID‐19 mortality in patients with diabetes: A systematic review and meta‐analysis
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 2
Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 2
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access
Medine Cumhur Cüre, Erkan Cüre
Current Pharmaceutical Design (2024) Vol. 30, Iss. 15, pp. 1149-1156
Closed Access
Focus on prevention in diabetes mellitus and lipid disorder
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 4, pp. 295-296
Closed Access | Times Cited: 1
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 4, pp. 295-296
Closed Access | Times Cited: 1
The Importance of a Novel Syndemic Approach for Cardiometabolic Diseases
Manfredi Rizzo
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2483-2485
Closed Access
Manfredi Rizzo
Current Medicinal Chemistry (2023) Vol. 31, Iss. 18, pp. 2483-2485
Closed Access
Cardiovascular preventive actions
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 6, pp. 497-498
Open Access
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 9, Iss. 6, pp. 497-498
Open Access
Cardiovascular prevention and risk factors
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 1, pp. 1-2
Open Access
Stefan Agewall
European Heart Journal - Cardiovascular Pharmacotherapy (2023) Vol. 10, Iss. 1, pp. 1-2
Open Access
